Not Yet RecruitingPhase 4

Randomized Trial of Combination Treatment With Sofwave and Sculptra

United States13 participantsStarted 2026-04-01

Plain-language summary

Evaluation of treatment on the upper arm with Sculptra and Sofwave on the same day versus Sofwave followed by Sculptra 1 month later.

Age range40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Male and female subjects ≥ 40 years old
✓. Able to provide informed consent
✓. Baseline level of upper arm skin flaccidity and volume loss as defined as type III or greater on the Arm Visual Analog Scale (Arm VAS) for aging

GAIS skin laxity

Timeframe: From treatment to 3 months after treatment

NCT IDNCT07342452

SponsorMassachusetts General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-04-01

Molly Wanner, MD